Full Project

Variant	Question	What it combines	Timing	From (USD)
Opportunity assessment	Is it worth entering this country with this product or portfolio, and where should we start?	Patient and value sizing, competition, access route, reference price, 3-year scenarios, recommendation	6 weeks, one country	20,000
Business case	Is the investment justified, and under what conditions?	All of the above plus a revenue model and, depending on scope, margin after acquisition cost, launch investment and payment terms; includes a 6-interview KHIN Panel	8 weeks, one country	30,000
Access and pricing strategy	How do I secure coverage, and at what price, without hurting regional reference pricing?	Map of decision makers and processes, regional price corridor, 8-interview KHIN Panel, access plan with sequence and arguments	8 weeks, one country	32,000

Always included: A midpoint review to adjust course, a final 20 to 30 slide deck in your template if you prefer, an Excel model with editable assumptions, a methodology note, two working sessions and 30 days of follow-up questions.
More countries: Each additional country adds 40 to 60% of the base price and one to two weeks.
How it starts: Usually after a Decision Sprint or a KHIN Panel, once you have seen how we work. The proposal fits on two pages, with the question, the variant, the price and the schedule.

Book the 30-minute call

Not included

Implementation (negotiations with payers, presentations to committees on the client's behalf), quantitative surveys, and formal clinical or pharmacoeconomic studies. Implementation support can be agreed separately as working sessions with a defined scope; the rest we refer to partners.

Not included

Start with the decision your team has to make.